
ANIX
Healthcare · Biotechnology · $91.1M market cap
$2.62-0.06 (-2.2%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Oct 31, 2026
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Sep 9, 2026 | After the close | -0.08 | -0.08 | 0.0% |
| Jun 10, 2026 | After the close | -0.10 | -0.07 | +30.0% |
| Mar 9, 2026 | After the close | -0.09 | -0.08 | +11.1% |
| Jan 7, 2026 | Time not confirmed | -0.08 | -0.08 | +4.0% |
| Sep 10, 2025 | After the close | -0.10 | -0.07 | +30.0% |
| May 28, 2025 | After the close | -0.10 | -0.09 | +10.0% |
| Mar 21, 2025 | After the close | -0.10 | -0.10 | 0.0% |
| Jan 10, 2025 | After the close | -0.11 | -0.09 | +18.2% |
| Sep 6, 2024 | After the close | -0.11 | -0.10 | +9.1% |
| Jun 4, 2024 | After the close | -0.11 | -0.10 | +9.1% |
| Mar 12, 2024 | After the close | -0.09 | -0.10 | -11.1% |
| Jan 16, 2024 | After the close | -0.09 | -0.09 | 0.0% |
| Sep 6, 2023 | After the close | -0.09 | -0.08 |
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development…
| +11.1% |
| Jun 14, 2023 | After the close | -0.11 | -0.07 | +36.4% |
| Mar 17, 2023 | Before the open | -0.16 | -0.08 | +50.0% |
| Jan 4, 2023 | After the close | -0.11 | -0.12 | -9.1% |
| Sep 9, 2022 | After the close | -0.13 | -0.09 | +30.8% |
| Jun 10, 2022 | After the close | -0.13 | -0.12 | +7.7% |
| Mar 11, 2022 | After the close | -0.13 | -0.13 | 0.0% |
| Jan 4, 2022 | After the close | -0.09 | -0.13 | -44.4% |
| Sep 1, 2021 | After the close | -0.08 | -0.14 | -75.0% |
| Jun 10, 2021 | After the close | -0.10 | -0.08 | +20.0% |
| Mar 11, 2021 | After the close | -0.11 | -0.07 | +36.4% |
| Jan 7, 2021 | After the close | -0.10 | -0.09 | +10.0% |
| Sep 8, 2020 | After the close | -0.12 | -0.11 | +8.3% |
| Jun 9, 2020 | After the close | -0.13 | -0.12 | +7.7% |
| Mar 9, 2020 | After the close | -0.13 | -0.13 | 0.0% |
| Jan 9, 2020 | After the close | -0.24 | -0.10 | +58.3% |
| Sep 6, 2019 | After the close | -0.23 | -0.11 | +52.2% |
| Jun 12, 2019 | Before the open | -0.23 | -0.13 | +43.5% |
| Mar 13, 2019 | After the close | -0.15 | -0.23 | -53.3% |
| Jan 11, 2019 | After the close | -0.15 | -0.26 | -73.3% |
| Sep 7, 2018 | After the close | — | -0.30 | — |
| Jun 11, 2018 | Before the open | — | -0.08 | — |
| Mar 9, 2018 | Before the open | — | -0.11 | — |
| Jan 9, 2018 | Before the open | -0.12 | -0.12 | 0.0% |